DENVER (October 14, 2021)—Perkins Coie is pleased to announce that it is representing PharmaCann Inc., the largest privately held, vertically integrated cannabis company in the United States, in a merger agreement under which it will acquire LivWell Holdings, Inc., a multi-state cannabis cultivation and retail leader based in Colorado. For more information, please see PharmaCann’s press release.

The Perkins Coie deal team was led by mergers and acquisitions partners Kester Spindler and Danielle Fortier, M&A counsel David Martinez, M&A associates Blake Schell, Hannah Schuppner, and cannabis regulatory senior counsel Andrew Kline, cannabis regulatory partner Barak Cohen, and cannabis regulatory associate Jasmine Wetherell.

Upon completion of the planned merger, PharmaCann and LivWell would operate approximately 60 dispensaries and 11 cultivation and production facilities across eight states. The closing of the transaction is subject to customary closing conditions, including, among others, the expiration or termination of the waiting period under the Hart-Scott-Rodino Antitrust Improvements Act and state and municipal-level regulatory approvals.

Perkins Coie is a leading global law firm, dedicated to helping the world’s most innovative companies solve the legal and business challenges of tomorrow. Learn about our work and values here.

Media Inquiries: Please email Justin Cole, Head of Media Relations.